Alnylam Pharmaceuticals (ALNY.MX) Q1 2025 Earnings

13FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-20.18
-14.27
-8.36
-2.46

Details

Expected EPS
-12.083199119999998
Actual EPS
-13.264875
Surprise EPS
-1.18
Surprise Percent
+9.78%

Description

Alnylam Pharmaceuticals (ALNY.MX) has reported earnings of -13.264875 per share for Q1 2025.

0 Comments

Share your thoughts